276 related articles for article (PubMed ID: 11227787)
1. R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level.
Palmiter KA; Tyska MJ; Haeberle JR; Alpert NR; Fananapazir L; Warshaw DM
J Muscle Res Cell Motil; 2000; 21(7):609-20. PubMed ID: 11227787
[TBL] [Abstract][Full Text] [Related]
2. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy.
Tyska MJ; Hayes E; Giewat M; Seidman CE; Seidman JG; Warshaw DM
Circ Res; 2000 Apr; 86(7):737-44. PubMed ID: 10764406
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
[TBL] [Abstract][Full Text] [Related]
4. Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.
Yamashita H; Tyska MJ; Warshaw DM; Lowey S; Trybus KM
J Biol Chem; 2000 Sep; 275(36):28045-52. PubMed ID: 10882745
[TBL] [Abstract][Full Text] [Related]
5. Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium.
Palmer BM; Fishbaugher DE; Schmitt JP; Wang Y; Alpert NR; Seidman CE; Seidman JG; VanBuren P; Maughan DW
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H91-9. PubMed ID: 15001446
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.
Debold EP; Schmitt JP; Patlak JB; Beck SE; Moore JR; Seidman JG; Seidman C; Warshaw DM
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H284-91. PubMed ID: 17351073
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of Dictyostelium discoideum mutant myosins equivalent to human familial hypertrophic cardiomyopathy.
Fujita H; Sugiura S; Momomura S; Sugi H; Sutoh K
Adv Exp Med Biol; 1998; 453():131-7. PubMed ID: 9889823
[TBL] [Abstract][Full Text] [Related]
8. Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.
Lowey S; Lesko LM; Rovner AS; Hodges AR; White SL; Low RB; Rincon M; Gulick J; Robbins J
J Biol Chem; 2008 Jul; 283(29):20579-89. PubMed ID: 18480046
[TBL] [Abstract][Full Text] [Related]
9. Altered crossbridge kinetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.
Blanchard E; Seidman C; Seidman JG; LeWinter M; Maughan D
Circ Res; 1999 Mar; 84(4):475-83. PubMed ID: 10066683
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication.
Fujita H; Sugiura S; Momomura S; Omata M; Sugi H; Sutoh K
J Clin Invest; 1997 Mar; 99(5):1010-5. PubMed ID: 9062359
[TBL] [Abstract][Full Text] [Related]
11. The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin.
Sarkar SS; Trivedi DV; Morck MM; Adhikari AS; Pasha SN; Ruppel KM; Spudich JA
Sci Adv; 2020 Apr; 6(14):eaax0069. PubMed ID: 32284968
[TBL] [Abstract][Full Text] [Related]
12. Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitro.
Debold EP; Saber W; Cheema Y; Bookwalter CS; Trybus KM; Warshaw DM; Vanburen P
J Mol Cell Cardiol; 2010 Feb; 48(2):286-92. PubMed ID: 19799913
[TBL] [Abstract][Full Text] [Related]
13. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.
Fananapazir L; Dalakas MC; Cyran F; Cohn G; Epstein ND
Proc Natl Acad Sci U S A; 1993 May; 90(9):3993-7. PubMed ID: 8483915
[TBL] [Abstract][Full Text] [Related]
14. Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation.
Witjas-Paalberends ER; Ferrara C; Scellini B; Piroddi N; Montag J; Tesi C; Stienen GJ; Michels M; Ho CY; Kraft T; Poggesi C; van der Velden J
J Physiol; 2014 Aug; 592(15):3257-72. PubMed ID: 24928957
[TBL] [Abstract][Full Text] [Related]
15. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly.
Becker KD; Gottshall KR; Hickey R; Perriard JC; Chien KR
J Cell Biol; 1997 Apr; 137(1):131-40. PubMed ID: 9105042
[TBL] [Abstract][Full Text] [Related]
16. Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex.
Palmer BM; Wang Y; Teekakirikul P; Hinson JT; Fatkin D; Strouse S; Vanburen P; Seidman CE; Seidman JG; Maughan DW
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1939-47. PubMed ID: 18281382
[TBL] [Abstract][Full Text] [Related]
17. The R403Q myosin mutation implicated in familial hypertrophic cardiomyopathy causes disorder at the actomyosin interface.
Volkmann N; Lui H; Hazelwood L; Trybus KM; Lowey S; Hanein D
PLoS One; 2007 Nov; 2(11):e1123. PubMed ID: 17987111
[TBL] [Abstract][Full Text] [Related]
18. Molecular and phenotypic effects of heterozygous, homozygous, and compound heterozygote myosin heavy-chain mutations.
Alpert NR; Mohiddin SA; Tripodi D; Jacobson-Hatzell J; Vaughn-Whitley K; Brosseau C; Warshaw DM; Fananapazir L
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1097-102. PubMed ID: 15528230
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.
Cuda G; Fananapazir L; Zhu WS; Sellers JR; Epstein ND
J Clin Invest; 1993 Jun; 91(6):2861-5. PubMed ID: 8514894
[TBL] [Abstract][Full Text] [Related]
20. Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on β-myosin cross-bridge mechanics.
Farman GP; Muthu P; Kazmierczak K; Szczesna-Cordary D; Moore JR
J Appl Physiol (1985); 2014 Dec; 117(12):1471-7. PubMed ID: 25324513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
